FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

Revance Therapeutics, Inc.: revenue

One fact, its scope and the complete path back to the official record.

Period: 2020-01-01 – 2020-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/fa27d228-036a-490a-b76b-8c9dde5ea7fa

Reported value

$15.325M{"amount": 15325000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"}
Entity
Revance Therapeutics, Inc.
Metric
revenue
Period
2020-01-01 – 2020-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001479290-21-000057 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T14:41:26.423200+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001479290/revenue/2020-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.